Beam Therapeutics saw the highest growth of 2.59% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.59% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Beam Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Beam Therapeutics has been focused on protecting inventions in United States(US) with nine publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 50% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Beam Therapeutics is filings its patents. Among the top granted patent authorities, Beam Therapeutics has 50% of its grants in United States(US).
Regeneron Pharmaceuticals and Massachusetts Institute of Technology could be the strongest competitors for Beam Therapeutics
Patents related to rare diseases and genomics lead Beam Therapeutics's portfolio
Beam Therapeutics has the highest number of patents in rare diseases followed by, genomics and nanomedicine. For rare diseases, nearly 35% of patents were filed and 67% of patents were granted in Q2 2024.
Amyloidosis related patents lead Beam Therapeutics portfolio followed by cardiomyopathy, and sickle cell disease
Beam Therapeutics has highest number of patents in amyloidosis followed by cardiomyopathy, sickle cell disease, thalassemia, and hemoglobinopathies.
For comprehensive analysis of Beam Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
